SELECT COUNTRY

VIEW ALL

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

ALGERIA ANGOLA ARGENTINA AUSTRALIA AZERBAIJAN BAHREIN BELGIUM BENIN BOTSWANA BRAZIL BRUNEI BURKINA FASO CANADA CHILE CHINA COLOMBIA COTE D’IVOIRE CZECH REPUBLIC DOMINICAN REPUBLIC DRC ECUADOR EGYPT ETHIOPIA FINLAND FRANCE GABON GHANA GREENLAND GUINEA HUNGARY ICELAND INDIA INDONESIA IRAN IRAQ ITALY KAZAKHSTAN KENYA KUWAIT LESOTHO LIBERIA MADAGASCAR MALAWI MALAYSIA MALI MAURITANIE MEXICO MONGOLIA MOROCCO MOZAMBIQUE NAMIBIA NETHERLANDS NICARAGUA NIGER NIGERIA NORWAY PANAMA PAPUA NEW GUINEA PERU PHILIPPINES POLAND QATAR RUSSIA RWANDA SENEGAL SINGAPORE SLOVENIA SOMALI SOUTH AFRICA SOUTH KOREA SPAIN SWEDEN TAIWAN TANZANIA THAILAND TOGO TRINDAD & TOBAGO TURKEY TURKMENISTAN UAE UGANDA UKRAINE UNITED KINGDOM UNITED STATES VENEZUELA VIETNAM ZAMBIA ZIMBABWE

UNITED STATES: LATEST INTERVIEWS MORE INTERVIEWS

Peter Meath

MANAGING DIRECTOR & CO-HEAD OF HEALTHCARE AND LIFE SCIENCES,...

.P.Morgan explains the complete ecosystem that it has developed for life science companies, aiming to serve their needs throughout their entire life cycle, from opening a bank account on Day 1, to expanding internationally and through a potential IPO and beyond.

United States

Pharmaceuticals

John Patrick Oroho

EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER, PORZIO...

Porzio Life Sciences, LLC (PorzioLS) is a provider of compliance operations products and services for the life sciences industry, and a wholly‐owned subsidiary of the Porzio, Bromberg & Newman, P.C. law firm.

United States

Pharmaceuticals

Ciara Kennedy

PRESIDENT AND CEO, AMPLYX PHARMACEUTICALS

Amplyx Pharmaceuticals has a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients.

United States

Pharmaceuticals

Nataliya Katsnelson

DIRECTOR – BUSINESS DEVELOPMENT, GLOBAL CLINICAL TRIALS

GCT is a CRO providing clinical development services for drugs and medical devices, with operations focused on Central and Eastern Europe, Russia and India.

United States

Pharmaceuticals